Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Treiner

Showing results (11-20 of 38) with videos related to

Pageof 4
Sort By:
Rheumatology (Oxford, England)|May 29, 2025
Interferon-γ release assay as an emergent powerful biomarker in systemic lupus erythematosusYves Renaudineau, Emmanuel Treiner, Fabrice Herin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat modelNathalie T Joncker, Nadine C Fernandez, Emmanuel Treiner, et al.
Microbes and Infection|March 22, 2005
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subsetEmmanuel Treiner, Livine Duban, Ivan Cruz Moura, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 2022
Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 responseYves Renaudineau, Florence Abravanel, Jacques Izopet, et al.
Journal of Neurology|June 2, 2022
Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progressionGuillaume Dorcet, Hugo Migné, Damien Biotti, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2021
MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutationsThibault Comont, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.
Multiple Sclerosis and Related Disorders|February 15, 2023
2 grams versus 1 gram rituximab as maintenance schedule in multiple sclerosis, neuromyelitis optica spectrum disorders and related diseases: What B-cell repopulation data tell usCelso Rual, Damien Biotti, Zoe Lepine, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2015
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patientsLuciane Zabijak, Christophe Attencourt, Caroline Guignant, et al.
Journal of Translational Autoimmunity|April 11, 2023
Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosusYves Renaudineau, Chloé Bost, Florence Abravanel, et al.
Rheumatology (Oxford, England)|August 18, 2025
Urinary soluble CD163 is useful to predict lupus nephritis activity and to monitor standard-of-care therapy responseYves Renaudineau, Emmanuel Treiner, Magali Colombat, et al.
Pageof 4

Showing results (11-20 of 38) with videos related to

Sort By:
Pageof 4
Rheumatology (Oxford, England)|May 29, 2025
Interferon-γ release assay as an emergent powerful biomarker in systemic lupus erythematosusYves Renaudineau, Emmanuel Treiner, Fabrice Herin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 4, 2009
NK cell responsiveness is tuned commensurate with the number of inhibitory receptors for self-MHC class I: the rheostat modelNathalie T Joncker, Nadine C Fernandez, Emmanuel Treiner, et al.
Microbes and Infection|March 22, 2005
Mucosal-associated invariant T (MAIT) cells: an evolutionarily conserved T cell subsetEmmanuel Treiner, Livine Duban, Ivan Cruz Moura, et al.
Clinical Immunology (Orlando, Fla.)|March 18, 2022
Novel T cell interferon gamma release assay (IGRA) using spike recombinant protein for COVID19 vaccine response and Nucleocapsid for SARS-Cov2 responseYves Renaudineau, Florence Abravanel, Jacques Izopet, et al.
Journal of Neurology|June 2, 2022
Early B cells repopulation in multiple sclerosis patients treated with rituximab is not predictive of a risk of relapse or clinical progressionGuillaume Dorcet, Hugo Migné, Damien Biotti, et al.
Cancer Immunology, Immunotherapy : CII|September 3, 2021
MAIT cells numbers and frequencies in patients with acute myeloid leukemia at diagnosis: association with cytogenetic profile and gene mutationsThibault Comont, Marie-Laure Nicolau-Travers, Sarah Bertoli, et al.
Multiple Sclerosis and Related Disorders|February 15, 2023
2 grams versus 1 gram rituximab as maintenance schedule in multiple sclerosis, neuromyelitis optica spectrum disorders and related diseases: What B-cell repopulation data tell usCelso Rual, Damien Biotti, Zoe Lepine, et al.
Cancer Immunology, Immunotherapy : CII|October 27, 2015
Increased tumor infiltration by mucosal-associated invariant T cells correlates with poor survival in colorectal cancer patientsLuciane Zabijak, Christophe Attencourt, Caroline Guignant, et al.
Journal of Translational Autoimmunity|April 11, 2023
Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosusYves Renaudineau, Chloé Bost, Florence Abravanel, et al.
Rheumatology (Oxford, England)|August 18, 2025
Urinary soluble CD163 is useful to predict lupus nephritis activity and to monitor standard-of-care therapy responseYves Renaudineau, Emmanuel Treiner, Magali Colombat, et al.
Pageof 4